Prevalence, predictors, and outcomes of early adherence after starting or changing antiretrovial therapy

AIDS Patient Care and STDs

Volumn 16, Issue 4, 2002, Pages 157-172

  Mathews, W Christopher ^a   Mar Tang, Moira ^a   Ballard, Craig ^a   Colwell, Brad ^a   Abulhosn, Kari ^a   Noonan, Craig ^a   Barber, R Edward ^a   Wall, Tamara L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT MONITORING; PREDICTION; PREVALENCE; PROGNOSIS; SCORING SYSTEM; SELF REPORT; SUBSTANCE ABUSE; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; LOGISTIC MODELS; MALE; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES;

EID: 0036228022     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/10872910252930867     Document Type: Article

References (40)

1. Anti-retroviral therapy in adults. Updated recommendations of the International AIDS Society - USA Panel
2. Adherence, compliance, and HAART
3. Potential factors affecting adherence with HIV therapy
4. Adherence to HIV combination therapy
5. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
6. Anti-retroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring
7. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS
8. Elements of success in HIV clinical care: Multiple interventions that promote adherence
9. How much adherence is enough? A prospective study of adherence to protease inhibitor therapy using MEMSCaps
10. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response
11. Factors affecting adherence to anti-retroviral therapy
12. 1993. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
13. Efficacy of the Substance Abuse Subtle Screening Inventory-3 (SASSI-3) in identifying substance dependence disorders in clinical settings
14. Measurement of drinking behavior using the Form 90 family of instruments
15. The reliability of Form 90: An instrument for assessing alcohol treatment outcome
16. Short form of depression inventory: Cross-validation
17. Mini-Mental State Examination (MMSE)
18. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity
19. Construct validation of the health belief model
20. Clinical pharmacokinetics of nucleoside antiretroviral agents
21. Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations
22. Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection
23. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments
24. Coefficient alpha and the internal structure of tests
25. Logistic Regression
26. Worst-rank score analysis with informatively missing observations in clinical trials
27. Trial design in the era of highly effective antiviral drug combinations for HIV infection
28. A meta-analysis of the effects of the HIV-1 RNA methodology on estimates of HIV-1 RNA undetectability in trials of HAART
29. Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial
30. A comparison study of multiple measures of adherence to HIV protease inhibitors
31. Improving on a coin toss to predict patient adherence to medications
32. Compliance with zidovudine in patients infected with human immunodeficiency virus, type 1: A cross-sectional study in a municipal hospital clinic
33. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease
34. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens